BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8140495)

  • 1. [Hemorrhagic complications in patients treated with oral anticoagulants].
    Amian A; Rodríguez JN; Diéguez JC; Cañavate M; Fernández A; Martino ML; Muñiz R; Prados D
    Sangre (Barc); 1993 Oct; 38(5):349-53. PubMed ID: 8140495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment with oral anticoagulants (acenocoumarol): influence of the initial doses in the incidence of hemorrhagic and thromboembolic episodes].
    Amian A; Rodríguez JN; Muñiz R; Diéguez JC; Cañavate M; Fernández-Jurado A; Martino ML; Prados D
    Sangre (Barc); 1994 Dec; 39(6):413-6. PubMed ID: 7855691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risks of oral anticoagulant therapy with increasing age.
    Torn M; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2005 Jul; 165(13):1527-32. PubMed ID: 16009869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemorrhagic complications and thrombotic phenomena in oral anticoagulation of elderly patients].
    Selva O'Callaghan A; San José Laporte A; Fuentes Camps I; Nicolau Fuste J; Piqueras Carrasco J; Vilardell Tarres M
    Rev Clin Esp; 1997 May; 197(5):323-8. PubMed ID: 9280965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients' perceptions regarding oral anticoagulation therapy and its effect on quality of life.
    Casais P; Meschengieser SS; Sanchez-Luceros A; Lazzari MA
    Curr Med Res Opin; 2005 Jul; 21(7):1085-90. PubMed ID: 16004677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of a bleeding risk index in two cohorts of patients treated with oral anticoagulants.
    van der Meer FJ; Rosendaal FR; Vandenbroucke JP; Briët E
    Thromb Haemost; 1996 Jul; 76(1):12-6. PubMed ID: 8819244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemorrhagic complications from anticoagulant treatment: analysis of predictive risk factors].
    Vázquez Ruiz de Castroviejo E; del Monte Trujillo Pérez M; Lozano Cabezas C; Avellaneda Molina C; Guzmán Herrera M; Martínez Galiano E; Pousibet Sanfeliú H; Tarabini Castellani A; Pagola Vilardebó C; Alcalá Muñoz A
    Sangre (Barc); 1999 Jun; 44(3):216-21. PubMed ID: 10481584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute hemorrhage due anti-vitamin K agents. A prognostic and descriptive study].
    Ben Ameur Y; Chaabane O; Zairi I; Longo S; Battikh K; Slimane ML
    Tunis Med; 2009 Nov; 87(11):763-9. PubMed ID: 20209835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of the stability of oral anticoagulant treatments (warfarin vs acenocoumarol)].
    Amián A; Rodríguez JN; Muñiz R; Diéguez JC; Moreno MV; Quesada JA; Cañavate M; Fernández-Jurado A; Martino ML; Prados D
    Sangre (Barc); 1996 Feb; 41(1):9-11. PubMed ID: 8779047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk of chronic oral anticoagulant treatment in elderly patients].
    Braun S; Chamorro G; Wilson C; Casanegra P; Corbalán R; Iirarrázaval MJ; Kobus C; Valle I
    Rev Med Chil; 1992 May; 120(5):552-8. PubMed ID: 1343069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding. A Multicenter Inception Cohort Study.
    Pengo V; Legnani C; Noventa F; Palareti G;
    Thromb Haemost; 2001 Mar; 85(3):418-22. PubMed ID: 11307807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low incidence of hemorrhagic complications of oral anticoagulant therapy in patients with atrial fibrillation in the daily practice of an anticoagulation clinic.
    Poli D; Antonucci E; Lombardi A; Cecchi E; Corsini I; Gensini GF; Abbate R; Prisco D
    Ital Heart J; 2003 Jan; 4(1):44-7. PubMed ID: 12690920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic.
    Cortelazzo S; Finazzi G; Viero P; Galli M; Remuzzi A; Parenzan L; Barbui T
    Thromb Haemost; 1993 Apr; 69(4):316-20. PubMed ID: 8497842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of a moderate with moderate-high intensity oral anticoagulant treatment in patients with mechanical heart valve prostheses.
    Pengo V; Barbero F; Banzato A; Garelli E; Noventa F; Biasiolo A; Zasso A; Dalla Volta S
    Thromb Haemost; 1997 May; 77(5):839-44. PubMed ID: 9184389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors of vitamin K antagonist overcoagulation. A case-control study in unselected patients referred to an emergency department.
    Cadiou G; Varin R; Levesque H; Grassi V; Benichou J; Tiret I; Dieu B; Lecam-Duchez V; Borg JY; Muller JM; Benhamou Y; Marie I
    Thromb Haemost; 2008 Oct; 100(4):685-92. PubMed ID: 18841293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Safety of oral anticoagulation in aged patients with heart diseases].
    García Garay MC; Marín Ortuño F; Roldán Schilling V; Martínez Martínez JG; Marco Vera P; Sogorb Garri F
    Rev Clin Esp; 1998 May; 198(5):294-6. PubMed ID: 9658911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Major thromboembolic complications during oral anticoagulant therapy. Importance of level of anticoagulation].
    de Vicente Cámara MP; Lucía Cuesta JF; Aguilar Franco C; Solano Bernad V; Serrano González C; García-Erce JA
    Sangre (Barc); 1999 Dec; 44(6):469-72. PubMed ID: 10822762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The frequency of risk factors of thromboembolic and hemorrhagic complications in patients treated with oral anticoagulants after heart valve replacement].
    Wołkanin-Bartnik J; Zieliński T; Pogorzelska H; Browarek A; Leszek P; Korewicki J
    Pol Merkur Lekarski; 2005 May; 18(107):503-10. PubMed ID: 16161943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
    Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.